Cat. No. 6151
Chemical Name: 5-(6-(4-(1-Piperazinyl)phenyl)pyraz
Biological ActivityPotent ALK inhibitor (IC50 values are 1.3, 2.4, 85.8, 2,133 and 9,276 nM for ALK2, ALK1, ALK3, ALK4 and ALK5, respectively). Exhibits selectivity for ALK2 over ALK4 and ALK5 in cellular assays. Inhibits heterotopic ossification in a mutant ALK2 mouse model of fibrodysplasia ossificans progressiva. Also exhibits activity against RIPK2, ABL1 and PDGFR-β (IC50 values < 100 nM).
Licensing InformationSold for research purposes under exclusive agreement from The Brigham and Women's Hospital Inc. US patent 14/776,302
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Mohedas et al (2013) Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem.Biol. 8 1291. PMID: 23547776.
If you know of a relevant reference for LDN 212854 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses LDN 212854 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: LDN 212854, supplier, LDN212854, ALK, inhibitors, inhibits, potent, in, vivo, active, BMP1, ALK2, bone, morphogenetic, protein, type, I, Tocris Bioscience, BMP and Other Activin Receptor Inhibitor products
Find multiple products by catalog number
New Products in this Area
August 20 - 24, 2017
Paris , France